
|Articles|May 12, 2023
Pharma 2023: Vaccines Journey to the Consumer
Stefan Merlo, Vice President, Commercial Development, CSL Seqirus discusses how COVID-19 has evolved the discussion of vaccines and the long-term concerns stemming from flu vaccine fatigue.
Advertisement
At Pharma 2023 in Barcelona, Stefan Merlo, Vice President, Commercial Development at CSL Seqirus, discussed the global vaccine journey, the connected customer experience and the role of consumer and government education to improve public health.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Releases Open Letter Warning of Potential Safety Risks for Compounded Tirzepatide Plus Vitamin B12
2
What is Shadow AI and How is it Impacting Pharma Companies?
3
Agentic AI and the Future of Commercial Excellence in Life Sciences
4
Novo Nordisk Responds to FDA’s Warning Letter Regarding 2025 PADE Inspection
5




